A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: Enhancing the secretion of chylomicrons

International Journal of Pharmaceutics

Volumn 445, Issue 1-2, 2013, Pages 141-147

  Fan, Zhuoyang ^a   Wu, Juan ^a   Fang, Xiaoling ^a   Sha, Xianyi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Caco 2 cell; Chylomicron; Lymphatic transport; Probucol; Vitamin E TPGS

Indexed keywords

ALPHA TOCOPHEROL; CHYLOMICRON; PROBUCOL; TOCOFERSOLAN;

ANIMAL EXPERIMENT; ARTICLE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; LIPOPHILICITY; LYMPHATIC SYSTEM; MALE; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CHYLOMICRONS; DRUG CARRIERS; HUMANS; INTESTINES; LYMPHATIC VESSELS; MALE; POLYETHYLENE GLYCOLS; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 84874939545     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.070     Document Type: Article

References (32)

1. K. Anwar, H.J. Kayden, and M.M. Hussain Transport of Vitamin E by differentiated Caco-2 cells J. Lipid Res. 47 2006 1261 1273
2. P. Artursson Epithelial transport of drugs in cell culture. I. A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells J Pharm Sci 79 1990 476 482
3. A. Bjorneboe, G.E. Bjorneboe, and C.A. Drevon Absorption, transport and distribution of Vitamin E J. Nutr. 120 1990 233 242
4. S.M. Caliph, W.N. Charman, and C.J.H. Porter Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J. Pharm. Sci. 89 2000 1073 1084
5. T. Chang, L.Z. Benet, and M.F. Hebert The effect of water-soluble Vitamin E on cyclosporine pharmacokinetics in healthy volunteers Clin. Pharmacol. Ther. 59 1996 297 303
6. A. Dahan, and A. Hoffman Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs Eur. J. Pharm. Sci. 24 2005 381 388
7. C.F. Daher, G.M. Baroody, and R.J. Howland Effect of a surfactant Tween 80, on the formation and secretion of chylomicrons in the rat Food Chem. Toxicol. 41 2003 575 582
8. G.A. Edwards, C.J.H. Porter, S.M. Caliph, S.M. Khoo, and W.N. Charman Animal models for the study of intestinal lymphatic drug transport Adv. Drug Deliv. Rev. 50 2001 45 60
9. F.J. Field, E. Albright, and S.N. Mathur Regulation of triglyceride-rich lipoprotein secretion by fatty acids in Caco-2 cells J. Lipid Res. 29 1988 1427 1437
10. L. Fossati, R. Dechaume, E. Hardillier, D. Chevillon, C. Prevost, S. Bolze, and N. Maubon Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs Int. J. Pharm. 360 2008 148 155
11. A.Y. Jaime, W.J.W. Stephen, W.K. Ian, A.W. Mark, and B.A. Kevin Intestinal lymphatic transport for drug delivery Adv. Drug Deliv. Rev. 63 2011 923 942
12. D.M. Karpf, R. Holm, H.G. Kristensen, and A. Müllertz Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats Pharm. Res. 21 2004 1413 1418
13. S.M. Khoo, D.M. Shackleford, C.J.H. Porter, G.A. Edwards, and W.N. Charman Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs Pharm. Res. 20 2003 1460 1465
14. M.L. Lind, J. Jacobsen, R. Holm, and A. Müllertz Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms Eur. J. Pharm. Sci. 32 2007 261 270
15. M.L. Lind, J. Jacobsen, R. Holm, and A. Müllertz Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80 Eur. J. Pharm. Sci. 35 2008 211 218
16. J. Luchoomun, and M.M. Hussain Assembly and secretion of chylomicrons by differentiated Caco-2 cells: nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly J. Biol. Chem. 274 1999 19565 19572
17. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug aclitaxel (Taxol): PLGA nanoparticles containing Vitamin E-TPGS J. Control Release 86 2003 33 48
18. F.S. Nielsen, K.B. Petersen, and A. Müllertz Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state Eur. J. Pharm. Biopharm. 69 2008 553 562
19. C.M. O'Driscoll Lipid-based formulations for intestinal lymphatic delivery Eur. J. Pharm. Sci. 15 2002 405 415
20. F.J. Plou, M. Ferrer, O.M. Nuero, M.V. Calvo, M. Alcalde, F. Reyes, and A. Ballasteros Analysis of Tween 80 as an esterase/lipase substrate for lipolytic activity assay Biotechnol. Tech. 12 1998 183 186
21. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248
22. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
23. D.R. Prows, E.J. Murphy, and F. Schroeder Intestinal and liver fatty acid binding proteins differentially affect fatty acid uptake and esterification in L-cells Lipids 30 1995 907 910
24. B.D. Rege, J.P.Y. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 2002 237 246
25. S.S. Savolainen, T. Järvinen, K.A. Sasaki, H. Watanabe, and A. Urtii Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line Pharm. Res. 15 1998 1275 1280
26. ® block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells Pharm. Res. 20 2003 1085 1092
27. F. Seeballuck, E. Lawless, M.B. Ashford, and C.M. O'Driscoll Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model Pharm. Res. 21 2004 2320 2326
28. X.Y. Sha, and X.L. Fang Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs Int. J. Pharm. 272 2004 161 171
29. N.L. Trevaskis, C.J.H. Porter, and W.N. Charman Bile increases intestinal lymphatic drug transport in the fasted rat Pharm. Res. 22 2005 1863 1870
30. M.M. van Greevenbroek, G. van Meer, D.W. Erkelens, and T.W. de Bruin Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells Arteriosclerosis 121 1996 139 150
31. M.V.S. Varma, and R. Panchagnula Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability J. Pharm. Sci. 94 2005 1694 1704
32. M.V.S. Varma, and R. Panchagnula Enhanced oral paclitaxel absorption with Vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 25 2005 445 453